Adeptus Health (NYSE: ADPT) reported Q2 EPS of $0.48, $0.03 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $100.2 million versus the consensus estimate of $93.92 million.

2016 Guidance Reaffirmed

We continue to expect systemwide net patient services revenue, which includes revenue from our unconsolidated joint ventures, of $640.0 million to $670.0 million for the full year 2016. We expect Adjusted EBITDA of $110.0 million to $115.0 million and Adjusted earnings per share of $2.55 to $2.65 for the full year 2016.

For earnings history and earnings-related data on Adeptus Health (ADPT) click here.